Amgen’s second quarter results outpaced Wall Street’s expectations, with management emphasizing strong demand for its ...

Erythroid cell patterns in neoplasms show distinct genomic profile and poor venetoclax response, new research suggests.

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

For developers, OpenAI claims GPT-5 is its most powerful coding model to date, outperforming GPT-o3 in benchmarks and ...

Earnings season slows this week, with investors waiting on NVIDIA’s earnings on August 27. Retail sales and inflation ...

Strand Therapeutics announced on Thursday that it landed a $153 million Series B funding led by Kinnevik. The company’s ...

Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported ...

The Irish Times has teamed up with Amgen Irish Open to give one lucky subscriber the chance to win two Saturday tickets.

Clinical trial tech outfit Medidata has elevated a new strategy leader from within. | Clinical trial tech outfit Medidata has elevated a new strategy leader from within. Industry veteran Lisa ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 study titled Phase 3, ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.